bucladesine has been researched along with Benign Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Boyadjieva, N; Jabbar, S; Murugan, S; Sarkar, DK; Shrivastava, P; Zhang, C | 1 |
| Cho-Chung, YS | 1 |
| Anderson, C; Meade-Cobun, KS; Ruddon, RW | 1 |
| Hussa, RO | 1 |
| Amoureux, MC; Colpaert, FC; Palmier, C; Pauwels, PJ; Wurch, T | 1 |
| Tisdale, MJ | 1 |
| Andreasen, PA; Christensen, TH; Danø, K; Huang, JY; Nielsen, LS; Wilson, EL | 1 |
| Abell, CW; Monahan, TM | 1 |
| Jaffe, BM | 1 |
| Wolberg, WH | 1 |
| Burger, MM; Rapin, AM | 1 |
7 review(s) available for bucladesine and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
On the mechanism of cyclic AMP-mediated growth arrest of solid tumors.
Topics: Animals; Arginine; Bucladesine; Cell Division; Cyclic AMP; Female; Humans; Kinetics; Mammary Neoplasms, Experimental; Neoplasm Regression, Spontaneous; Neoplasms; Neoplasms, Experimental; Nucleoproteins; Phosphorylation; Rats; Receptors, Cyclic AMP | 1980 |
Biosynthesis of human chorionic gonadotropin.
Topics: Amino Acid Sequence; Animals; Bacteria; Bucladesine; Cell Membrane; Cells, Cultured; Chemical Phenomena; Chemistry; Choriocarcinoma; Chorionic Gonadotropin; DNA; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Mannose; Neoplasms; Oligosaccharides; Placenta; Pregnancy; RNA, Messenger; Thyrotropin; Tissue Distribution; Trophoblasts; Uterine Neoplasms | 1980 |
The significance of cyclic AMP and cyclic GMP in cancer treatment.
Topics: Adenylyl Cyclases; Animals; Bucladesine; Carcinogens; Cell Differentiation; Cell Division; Cell Transformation, Neoplastic; Cyclic AMP; Cyclic GMP; Humans; Neoplasms; Neoplasms, Experimental; Organ Specificity | 1979 |
The role of adenosine 3',5'-cyclic monophosphate in the regulation of mammalian cell division.
Topics: Adenylyl Cyclases; Animals; Bucladesine; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cells, Cultured; Concanavalin A; Contact Inhibition; Culture Media; Cyclic AMP; DNA; Fibroblasts; Growth Substances; HeLa Cells; Humans; Isoproterenol; L Cells; Lectins; Lymphocytes; Mammals; Mitogens; Mitosis; Neoplasms; Prostaglandins; Protein Precursors; RNA; Theophylline | 1973 |
Prostaglandins and cancer: an update.
Topics: Animals; Aspirin; Bucladesine; Calcium; Carcinoma; Cell Division; Cell Line; Depression, Chemical; HeLa Cells; Humans; Hypercalcemia; In Vitro Techniques; Indomethacin; Neoplasms; Neoplasms, Experimental; Prostaglandins; Radioimmunoassay; Sarcoma; Thyroid Neoplasms | 1974 |
Tumor cell surfaces: general alterations detected by agglutinins.
Topics: Agglutination; Animals; Antigens, Neoplasm; Binding Sites; Bucladesine; Cell Differentiation; Cell Division; Cell Membrane; Cell Transformation, Neoplastic; Contact Inhibition; Cyclic AMP; Electrophysiology; Fluorescent Antibody Technique; Glycolipids; Glycoproteins; Growth Substances; Humans; Insulin; Lectins; Lymphocyte Activation; Magnetic Resonance Spectroscopy; Models, Biological; Neoplasms; Peptide Hydrolases; Sialic Acids; Transferases; X-Ray Diffraction | 1974 |
1 trial(s) available for bucladesine and Benign Neoplasms
| Article | Year |
|---|---|
Reversal of cancer.
Topics: Antineoplastic Agents; Bucladesine; Cell Differentiation; Clinical Trials as Topic; Humans; Neoplasms; Thiazoles; Thiazolidines | 1983 |
5 other study(ies) available for bucladesine and Benign Neoplasms
| Article | Year |
|---|---|
Beta-endorphin cell therapy for cancer prevention.
Topics: Animals; Anticarcinogenic Agents; beta-Endorphin; Bucladesine; Carcinogens; Cell Differentiation; Disease Models, Animal; Female; Glucose Tolerance Test; Hypothalamus; Immune System; Immunohistochemistry; Killer Cells, Natural; Male; Neoplasm Metastasis; Neoplasms; Neurons; Rats; Rats, Inbred F344; Rats, Nude; Rats, Sprague-Dawley | 2015 |
Stimulation of synthesis and secretion of chorionic gonadotropin subunits by eutopic and ectopic hormone-producing human cell lines.
Topics: Bucladesine; Butyrates; Cell Line; Chorionic Gonadotropin; Hormones, Ectopic; Humans; Macromolecular Substances; Neoplasms | 1980 |
Stimulation of cloned human serotonin 5-HT1D beta receptor sites in stably transfected C6 glial cells promotes cell growth.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Brain Neoplasms; Bucladesine; Cell Division; CHO Cells; Cloning, Molecular; Colforsin; Cricetinae; Cyclic AMP; Genes; Glioma; Humans; Neoplasms; Rats; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Recombinant Proteins; Sequence Homology, Nucleic Acid; Serotonin Agents; Signal Transduction; Transfection; Tumor Cells, Cultured | 1996 |
Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Topics: Antibodies, Monoclonal; Bucladesine; Cell Line; Chromatography, Affinity; Dexamethasone; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fibrosarcoma; Glioma; Humans; Immunologic Techniques; Melanoma; Molecular Weight; Neoplasms; Plasminogen Activators; Plasminogen Inactivators; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1986 |
Inhibition of leukocyte migration by human tumors. Effect on patient survival.
Topics: Breast Neoplasms; Bucladesine; Cell Migration Inhibition; Colonic Neoplasms; Culture Media; Culture Techniques; Cyclic AMP; Cyclic GMP; Drug Synergism; Humans; Leukocytes; Lung Neoplasms; Neoplasms; Proteins; Theophylline; Tuberculin Test | 1974 |